Qiagen N.V.
XETRA: QIA.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Thierry L. Bernard
- Employees
- 5,700
- Headquarters
- Venlo, Netherlands
- IPO year
- 1998
- Market cap
- €5.8B
- Website
- https://www.qiagen.com
Loading QIA…
Loading profile data…Frequently asked questions about QIA
What does Qiagen N.V. (QIA.DE) do?
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
Where does QIA.DE trade?
Qiagen N.V. (QIA.DE) trades on the Deutsche Börse.
What sector is QIA.DE in?
Qiagen N.V. (QIA.DE) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Qiagen N.V.?
Thierry L. Bernard is the chief executive officer of Qiagen N.V. (QIA.DE).
Where is Qiagen N.V. headquartered?
Qiagen N.V. is headquartered in Netherlands.
Does QIA.DE pay a dividend?
Yes — Qiagen N.V. (QIA.DE) paid a trailing twelve-month dividend of EUR 0.22 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did QIA.DE go public?
Qiagen N.V. (QIA.DE) completed its initial public offering in 1998.